Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.06 USD | -0.10% | +22.34% | +15.71% |
May. 30 | Barrington Research Downgrades SurModics to Market Perform From Outperform | MT |
May. 29 | Needham Downgrades SurModics to Hold From Buy | MT |
Financials (USD)
Sales 2024 * | 123M | Sales 2025 * | 138M | Capitalization | 600M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -2M | EV / Sales 2024 * | 4.88 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.36 x |
P/E ratio 2024 * |
-54.1
x | P/E ratio 2025 * |
-271
x | Employees | 376 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.78% |
Latest transcript on Surmodics, Inc.
1 day | -0.10% | ||
1 week | +22.34% | ||
1 month | +63.72% | ||
3 months | +31.85% | ||
6 months | +28.15% | ||
Current year | +15.71% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Maharaj
CEO | Chief Executive Officer | 61 | 10-12-26 |
Timothy Arens
DFI | Director of Finance/CFO | 57 | 07-01-31 |
Teri L. Sides
PRN | Corporate Officer/Principal | 55 | 18-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Kalich
BRD | Director/Board Member | 77 | 14-02-16 |
Susan Knight
CHM | Chairman | 70 | 08-01-28 |
José Bedoya
BRD | Director/Board Member | 68 | 01-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.21% | 25 M€ | -2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 42.06 | -0.10% | 706,693 |
24-05-30 | 42.1 | -.--% | 1,203,949 |
24-05-29 | 42.1 | +19.94% | 2,897,500 |
24-05-28 | 35.1 | +2.09% | 42,927 |
24-05-24 | 34.38 | +0.47% | 22,389 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.71% | 600M | |
-7.16% | 178B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- SRDX Stock